GSK plc ADRhedged ETF (GSKH) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with GSKH. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to GSKH
GSKH charges 0.19% annually. There are 4 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.08%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| State Street Health Care Select Sector SPDR ETF | 0.08% | 38.47B | Dec 1998 | GSKH vs XLV | |
| Fidelity MSCI Health Care Index ETF | 0.08% | 2.99B | Oct 2013 | GSKH vs FHLC | |
| Vanguard Health Care ETF | 0.09% | 19.00B | Jan 2004 | GSKH vs VHT | |
| Portfolio Building Block World Pharma and Biotech ... | 0.13% | 9.98M | Nov 2025 | GSKH vs PBPH | |
| Invesco S&P SmallCap Health Care ETF | 0.29% | 142.99M | Apr 2010 | GSKH vs PSCH |
Best Risk-Adjusted Alternatives to GSKH
GSKH has a PortfoliosLab risk / return rank of 52. There are 26 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 96.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 96 | 40.93M | Dec 2014 | GSKH vs BBC | |
| ALPS Medical Breakthroughs ETF | 95 | 160.12M | Dec 2014 | GSKH vs SBIO | |
| SPDR S&P Biotech ETF | 94 | 8.62B | Feb 2006 | GSKH vs XBI | |
| iShares U.S. Pharmaceuticals ETF | 93 | 956.44M | May 2006 | GSKH vs IHE | |
| First Trust Nasdaq Pharmaceuticals ETF | 93 | 33.60M | Sep 2016 | GSKH vs FTXH |
Top Performing GSKH Alternatives (YTD)
GSKH is at 9.31% YTD. There are 28 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 43.01%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| ARK Genomic Revolution Multi-Sector ETF | 43.01% | 1.31B | Oct 2014 | GSKH vs ARKG | |
| Virtus LifeSci Biotech Clinical Trials ETF | 32.42% | 40.93M | Dec 2014 | GSKH vs BBC | |
| AdvisorShares Psychedelics ETF | 32.03% | 33.07M | Sep 2021 | GSKH vs PSIL | |
| Roundhill UNH WeeklyPay ETF | 29.71% | 4.79M | Dec 2025 | GSKH vs UNHW | |
| SPDR S&P Biotech ETF | 27.56% | 8.62B | Feb 2006 | GSKH vs XBI |
Lowest Volatility Alternatives to GSKH
GSKH has 26.18% 1-year volatility. There are 53 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 0.00%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | 9.68M | Jun 2020 | GSKH vs GERM | |
| Loncar Cancer Immunotherapy ETF | 0.00% | 12.73M | Oct 2015 | GSKH vs CNCR | |
| Horizon Kinetics SPAC Active ETF | 8.55% | 10.10M | Jun 2007 | GSKH vs SPAQ | |
| State Street Health Care Select Sector SPDR Premiu... | 11.05% | 14.95M | Jul 2025 | GSKH vs XLVI | |
| Global X Aging Population ETF | 13.76% | 80.19M | May 2016 | GSKH vs AGNG |
Lowest Drawdown Alternatives to GSKH
GSKH has a 1-year max drawdown of -18.54%. There are 48 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as 0.00%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | 9.68M | Jun 2020 | GSKH vs GERM | |
| Horizon Kinetics SPAC Active ETF | -4.60% | 10.10M | Jun 2007 | GSKH vs SPAQ | |
| First Trust Nasdaq Pharmaceuticals ETF | -7.47% | 33.60M | Sep 2016 | GSKH vs FTXH | |
| Invesco Nasdaq Biotechnology ETF | -8.34% | 68.94M | Jun 2021 | GSKH vs IBBQ | |
| iShares U.S. Pharmaceuticals ETF | -8.47% | 956.44M | May 2006 | GSKH vs IHE |
Other ETFs from ADRhedged
The 3 most viewed ADRhedged ETFs shown here include STHH, TMH, HSBH and span 3 categories. AUM among these funds goes as high as $8M.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| STMicroelectronics NV ADRhedged | Technology Equities | 82 | 182.81% | 7.89M | Mar 2025 | GSKH vs STHH | |
| Toyota Motor Corporation ADRhedged | Consumer Discretionary Equities | — | — | 1.16M | Mar 2025 | GSKH vs TMH | |
| HSBC Holdings plc ADRhedged ETF | Financials Equities | 89 | 26.16% | 5.04M | Oct 2024 | GSKH vs HSBH |
Often Compared With GSKH
Investors most often compare GSKH with PJP, MDEV, BMED. These 20 comparison targets span 4 categories, based on PortfoliosLab usage data.
Compare GSKH with Any Fund or Stock
Compare GSKH with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair GSKH with funds that move differently
GSK plc ADRhedged ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to GSKH.
Explore GSKH Diversifiers